Stock in Action: Endo Int'l Plc (ENDP)

Mae Love
November 22, 2017

Endo International plc (NASDAQ:ENDP) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges.

The stock's current distance from 20-Day Simple Moving Average (SMA20) is 13.53% where SMA50 and SMA200 are -3.19% and -26.96% respectively. Amalgamated Bank reported 0.02% in Endo International plc - Ordinary Shares (NASDAQ:ENDP). The rating was maintained by Stifel Nicolaus on Friday, October 20 with "Hold". Zacks Investment Research raised shares of Endo International PLC from a hold rating to a buy rating and set a $9.75 target price for the company in a research report on Wednesday, October 11th.

BMO Capital "Maintained" Endo Int'l Plc (NASDAQ:ENDP) in a research note issued to investors on 11/13/17 to Market Perform with price target of $10.

Endo International plc was covered by a number of analysts recently, 2 rated the stock as Buy, 14 rated Hold, 0 rated sell and 1 gave an Underperform. The stock presently has a consensus rating of Hold and a consensus target price of $11.67. Camber Capital Management Llc sold 1.48M shares as the company's stock declined 9.17% while stock markets rallied. The stock has a market cap of $1,683.79, a PE ratio of 1.56, a price-to-earnings-growth ratio of 2.05 and a beta of 0.53.

Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last posted its earnings results on Thursday, November 9th. Previously Endo Int'l Plc (NASDAQ:ENDP) reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.2 with surprise factor of 28.2%. It has a return on equity (ROE) of -309.70%.

Taking a broader look brokerage firms' analysts on the street with an expectant view have Endo Int'l Plc (NASDAQ:ENDP) high price target of $17 and with a conservative view have low price target of $6. During the same period past year, the firm posted $1.01 EPS.

Linkin Park Members Pay Tribute to Chester Bennington at 2017 AMAs
They said in a statement: "We dedicate this live album to our brother Chester who poured his heart and soul into 'One More Light'".

Trump Urges Vote for Roy Moore, Cites Candidate's Denial of Allegations
He further teased that he would let reporters know "next week" if he would campaign for Moore. "Well, he denies. He has denied the allegations. "[Moore's opponent Doug] Jones - I've looked at his record".

The Good Place Season 3 Confirmed
The series, another critical favorite from Michael Schur (" Parks and Recreation "), is midway through its sophomore season. The show is averaging a 1.2 rating among adults 18-49 and 4.3 million viewers for its initial airings this season.

Sell side analysts plays vital role in buying and selling a stock where 3 analysts rated Endo International plc (NASDAQ) as Buy, 0 analysts given Outperform signal, 5 reported Hold, and 0 analysts rated the stock as Sell.

COPYRIGHT VIOLATION WARNING: "Endo International PLC (NASDAQ:ENDP) Updates FY17 Earnings Guidance" was posted by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this article on another site, it was illegally copied and reposted in violation of USA & worldwide trademark & copyright law. "Similarly, the company's EVP, CFO Coleman Blaise on 2017-08-15 Buy 6500 shares of the company at a price of $7.89". Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland. With short interest at 21,891,550 and short average daily volume at 5,563,500, days to cover is 4.0 and the percentage of shorted shares was 0.10% on October 13.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 2.8 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. Riverhead Capital Management LLC boosted its stake in Endo International PLC by 64.4% in the second quarter.

In the past 5 years, the stock showed growth of -3.6% per annum. Finally, Bank of Hawaii purchased a new stake in Endo International PLC in the second quarter worth approximately $180,000. Hedge funds and other institutional investors own 91.88% of the company's stock.

The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER